logo
Intermittent therapy for the treatment of chronic HIV infection
In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype
Reduction in mother-to-child transmission of HIV in Thailand, 2001–2003: results from population-based surveillance in six provinces
Early archives of genetically-restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1
Determination of simian immunodeficiency virus production by infected activated and resting cells
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients
Food and Drug Administration analysis of tipranavir clinical resistance in HIV-1-infected treatment-experienced patients
Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients
The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals
Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis
Elevated risk of lung cancer among people with AIDS
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City
Prevalence of primary genotypic resistance in a UK centre: comparison of primary HIV-1 and newly diagnosed treatment-naive individuals
Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance
Salvage therapy with amprenavir, lopinavir and ritonavir is durably potent in HIV-infected patients in virological failure: 1-year results
No evidence of an increase in serosorting with casual partners among HIV-negative gay men in London, 1998–2005
Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers
Genetic diversity and population structure of Mycobacterium tuberculosis in HIV-1-infected compared with uninfected individuals in Burkina Faso
CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals
HIV–hepatitis C virus co-infection is associated with decreased plasmatic IL-7 levels
Efavirenz-associated podocyte damage
Continued correspondence ‘Will ART rollout in Africa drive an epidemic of drug-resistant HIV?’
Response to continued correspondence ‘Will ART rollout in Africa drive an epidemic of drug-resistant HIV?’
Rapid scaling-up of access to antiretroviral therapy in Mexico: is it better not to treat?
Late HIV seroconversion after non-occupational postexposure prophylaxis against HIV with concomitant hepatitis C virus seroconversion
Relapse of HIV-associated nephropathy after discontinuing highly active antiretroviral therapy
HLA-Cw8 primarily associated with hypersensitivity to nevirapine
K65R development among subtype C HIV-1-infected patients in tenofovir DF clinical trials
Reporting deficiencies in trials of abstinence-only programmes for HIV prevention
Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimen